Laia Munoz-Gomez
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
miR-30d-5p promotes beta cell recovery and immunomodulation in type 1 diabetes.
Journal: Frontiers in endocrinology
Published: March 25, 2026
Identification of Peripheral Blood Endotypes Associated With Age in Pediatric Type 1 Diabetes.
Journal: Pediatric diabetes
Published: March 08, 2025
Corrigendum: NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes.
Journal: Frontiers in immunology
Published: May 27, 2024
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Journal: Journal of autoimmunity
Published: January 15, 2024
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus.
Journal: Trends in endocrinology and metabolism: TEM
Published: September 01, 2023
Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion.
Journal: Non-coding RNA
Published: January 30, 2023
Fast-screening flow cytometry method for detecting nanoplastics in human peripheral blood.
Journal: MethodsX
Published: December 05, 2022
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells.
Journal: Archivum immunologiae et therapiae experimentalis
Published: July 28, 2022
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.
Journal: Frontiers in immunology
Published: November 30, 2021
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort.
Journal: Journal of diabetes research
Published: October 28, 2021
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
Journal: Frontiers in immunology
Published: September 29, 2020
Last Updated: 09/26/2026